Michael Ball

Executive Advisor, Canexia Health

Role: Associate

Sites: CDL-Toronto, CDL-Vancouver

Streams: Biomedical Engineering, Cancer

Michael Ball is the founder and CEO of Marketech Solutions, providing strategic expertise in the precision health, life sciences, genomics and diagnostics industries. Clients include early and mid-stage high-growth organizations, private equity and venture capitalists. Previously, Michael was the CEO of Canexia Health a clinical diagnostics company specializing in liquid biopsy testing for cancer patients. He is an accomplished B2B executive with a history of scaling global companies from startup, through acquisition and IPO. Prior to Canexia Health, Michael was the global vice president of informatics at Illumina, a $50B leader in the genomics space. He was also the CEO of GenoLogics a venture-backed start-up which was sold to Illumina. Michael served on the leadership team at Creo Products, during which time they executed a successful IPO. He is also active as an advisor and board member on companies in the digital health sector.